Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2006
02/08/2006CN1731157A Liquid enzyme agent for quick detection of residual pesticide toxicity and preparation method and using method thereof
02/08/2006CN1731155A Solid enzyme agent for quick detection of residual pesticide toxicity and preparation method and using method thereof
02/08/2006CN1731153A Biochip scanner employing large-stroke uniform speed scanning
02/08/2006CN1731152A All-fiber completely solidified biological micro-array chip scanner
02/08/2006CN1731151A Method for adipose-derived adult stem cell labeling by using exogenous green fluorescent protein (GFP)
02/08/2006CN1731150A A biochip method for detecting dioxin-type chemical species
02/08/2006CN1731146A A method for detecting alpha-L-fucosidase vitality and agent therefor
02/08/2006CN1731130A Apparatus for quick separation of pine wood nematode and detection method therefor
02/08/2006CN1730668A Molecular mark of watermelon linked to gene resistant to field pumpkin yellowwatermelon yellow mosaic virus and uses
02/08/2006CN1730667A Helicobacter pylori clarithromycin drug-resistant gene polymorphism detecting chip and its preparation method and uses
02/08/2006CN1730666A Method for detecting chicken fat property using mononucleotide polymorphism
02/08/2006CN1730665A PI3K enzyme inhibitor quick-speed screening method
02/08/2006CN1730664A Bacteria sum quick-speed detecting reagent kit and filtration cuvette using in detecting device
02/08/2006CN1730663A Oral mucosa epithelial cell canceration model
02/08/2006CN1730662A Method of qualitative and quantitative analysis for algae
02/08/2006CN1730659A Method for preparing mammal galactophore biological reactor using gene targeting technology
02/08/2006CN1730655A Human genetic deaf related GJB6 mutant gent and its uses in gennetic deaf diagnosis
02/08/2006CN1241016C Colorimetric experiment device capable of reducing error
02/08/2006CN1241012C Disposable test strips with integrated reagent/blood separation layer and forming method thereof
02/08/2006CN1240848C Method for detecting pathogeny of hog cholera
02/08/2006CN1240847C Reagent box for determining infectious chicken anemia
02/08/2006CN1240836C Transforming growth factor alpha HI
02/08/2006CN1240835C Nucleotide specific to o antigen of colibacillus 0-59
02/08/2006CN1240834C LY6H gene
02/07/2006US6996476 Methods and systems for gene expression array analysis
02/07/2006US6996475 Computer software products for nucleic acid hybridization analysis
02/07/2006US6996474 Automated method for identifying related biomolecular sequences
02/07/2006US6996473 Method for screening and producing compound libraries
02/07/2006US6995386 Fluorescence detecting device with integrated circuit and photodiode, and detection method
02/07/2006US6995299 Model system for Hepatitis C virus infection in humans, comprising non-human animal rendered immunologically tolerant to human hepatocytes and subsequently transplanted with human hepatocytes and infected with Hepatitis C
02/07/2006US6995258 Nucleolar targeting of therapeutics against HIV
02/07/2006US6995257 Notch3 gene and the corresponding protein, which are involved in CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy); probes and primers; mutations in gene that indicate risk of developing CADASIL
02/07/2006US6995252 A polynucleotide encoding a perinuclear thecaprotein (PT 32) which binds to tyrosine kinase c-Yes to induce oocyte activation; enhancing fertility, treating or diagnosing diminished fertility and/or abnormal spermiogenesis; contraception; screeing
02/07/2006US6995249 Nucleic acid capable of binding specifically to Ras target protein
02/07/2006US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries
02/07/2006US6995240 Treatment of inflammatory disease
02/07/2006US6995239 An amino acid sequence of a protein which is capable of modulating hyphal growth in fungus, e.g. Aspergillus; controlling gene expression; plant growth regulators; fungicides
02/07/2006US6995146 Compositions and methods for treatment of hepatitis C virus-associated diseases
02/07/2006US6995134 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics
02/07/2006US6995020 Pressure cooking sample with ammonia, ethanol in sodium borohydride; pretreatment of FISH analysis, reduce the tissue autofluorescence for improving the detection of mRNA transcripts in paraffin-embedded tissue
02/07/2006US6995017 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
02/07/2006US6995004 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT
02/07/2006US6994998 substituting a base-modified nucleotide that renders the polynucleotide more susceptible to cleavage at the sites of its incorporation for a natural nucleotide in a polynucleotide; 1-ribose-4-amino-5-hydroxy-1,2-dihydropyrimidin-2-one for example
02/07/2006US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases
02/07/2006US6994985 use of the interaction of bacteriophage T4 AsiA protein and the C-terminal DNA binding domain of sigma factor (the SR4 domain) to screen for agents capable of binding and inhibiting sigma factor activity; screening for microbiocides for pathogens
02/07/2006US6994984 Kits for monitoring blood coagulation and stabilty of bodily fluids
02/07/2006US6994983 Determining asprin dosage by measuring concentration of metabolitein urine using antbody and color indicator; side effect reduction; drug resistance; kits
02/07/2006US6994980 Chemiluminescent compounds and use thereof
02/07/2006US6994978 Human osteoclast derived cathepsin
02/07/2006US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex
02/07/2006US6994973 Using orthocresolphthalein complex test strip to determine calcium and magnesium concentrations in aqueous samples; colorimetric analysis; water potability; water treatment
02/07/2006US6994972 Porous substrates for DNA arrays
02/07/2006US6994971 does not require reattachment of the target sequence to a solid support to perform the second step, does not require Polymerase Chain Reaction (PCR), highly quantitative, uses readily available laboratory equipment; magnetic and nonmagnetic beads
02/07/2006US6994969 Combination of several different mass spectra, obtained after complementary digestion reactions, coupled with systematic computational analysis leads to the unambiguous assignment of both known and previously unknown sequence variations
02/07/2006US6994968 BK beta subunits of Slo family potassium channels
02/07/2006US6994967 Transcription factor regulators and methods for screening for same
02/07/2006US6994966 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
02/07/2006US6994965 Visual comfirmation of similarity score calculated from base sequences of probe biopolymers represented by, e.g., square patterns having varying depths in color; accuracy; side by side display for comparison; unexpected hybridization; microarrays
02/07/2006US6994964 Macromolecular arrays on polymeric brushes and methods for preparing the same
02/07/2006US6994963 Methods for recombinatorial nucleic acid synthesis
02/07/2006US6994962 Methods of identifying point mutations in a genome
02/07/2006US6994961 Detecting the presence of or predisposition to an ectodermal disorder such as Clouston syndrome associated with misexpression of a TAJ gene, a member of the tumor necrosis factor receptor family
02/07/2006US6994960 Detecting a mutation between a nucleic acid molecule to be tested and a reference nucleic acid molecule by base specific cleavage followed by Matrix-Assisted Laser Desorption/Ionization MS; does it require a gel electrophoresis step
02/07/2006US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases
02/07/2006US6994958 Methods for separating and/or identifying DNA molecules
02/07/2006US6994957 Using nucleic acid
02/07/2006US6994956 combining with radiolabelled substrate, adding phase-partition scintillation fluid, then incubating within single vessel comprising multiwell plates; for screening compounds for treatment of diabetes, obesity, cardiovascular disease, and cancer
02/07/2006US6994955 Complex of lipoprotein and hemoglobulin; analyzing
02/07/2006CA1341495C Method for detecting nucleic acid sequences
02/02/2006WO2006012646A2 Amacr cancer markers
02/02/2006WO2006012588A2 Methods and devices for diagnosis of appendicitis
02/02/2006WO2006012518A2 METHOD AND COMPOSITIONS INVOLVING PROTEIN KINASE-δ
02/02/2006WO2006012507A2 Methods and compositions for risk stratification
02/02/2006WO2006012468A2 Detection of oligonuleotides by dual hybridization
02/02/2006WO2006012451A2 Compositions and methods of use for mgd-csf in disease treatment
02/02/2006WO2006012361A2 Genetic markers for predicting disease and treatment outcome
02/02/2006WO2006012356A2 Methods for determining risk of developing regular smoking behavior
02/02/2006WO2006012351A2 Markers for brain damage
02/02/2006WO2006012302A2 Methods for rna fluorescence in situ hybridization
02/02/2006WO2006012222A2 Methods of treating smooth muscle cell disorders
02/02/2006WO2006012154A1 A method for detecting reactive metabolites using stable-isotope trapping and mass spectroscopy
02/02/2006WO2006012134A2 Genetic diagnostic method for scd risk stratification
02/02/2006WO2006012105A1 Two-hybrid system
02/02/2006WO2006012078A2 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
02/02/2006WO2006011678A1 Hybridization apparatus and hybridization method
02/02/2006WO2006011667A1 METHOD OF MEASURING HETEROGENOUS NCULEAR NIBONUCLEOPROTEIN B1 (hnRNP B1) mRNA
02/02/2006WO2006011589A1 Method of preparing artificial gene population and artificial protein population by random polymerization of motif sequences of multiple types
02/02/2006WO2006010948A1 Method for determining the amount of template nucleic acid present in a sample
02/02/2006WO2006010940A1 Method of assaying fad synthetase
02/02/2006WO2006010920A1 Soluble polypeptide
02/02/2006WO2006010610A2 Method for determining the abundance of sequences in a sample
02/02/2006WO2006010517A2 Diagnostics and therapeutics for diseases associated with fibroblast activation protein (fap)
02/02/2006WO2006010514A2 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5)
02/02/2006WO2006010499A2 Diagnostics and therapeutics for diseases associated with carboxypeptidase a2 (cpa2)
02/02/2006WO2006010498A2 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2)
02/02/2006WO2006010497A2 Diagnostics and therapeutics for diseases associated with choline kinase (chk)
02/02/2006WO2006010494A2 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 1 (metapi)
02/02/2006WO2006010492A1 Diagnostics and therapeutics for diseases associated with tryptase 1 (tps1)
02/02/2006WO2005118882A3 Method for the taxon-specific identification of cells of gram-positive bacteria and devices for carrying out said method
02/02/2006WO2005118838A3 Adjustable test system for the determination of the presence of an antibiotic in a fluid